A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer
Authors Xu K, Liu B, Ma Y, Xu B, Xing X
Received 17 May 2018
Accepted for publication 25 June 2018
Published 4 September 2018 Volume 2018:10 Pages 3245—3254
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Antonella D'Anneo
Ke Xu,1 Bin Liu,2 Yegang Ma,1 Baojin Xu,3 Xiaojing Xing1
1Department of Thoracic Surgery, Cancer Hospital of China Medical University, Shenyang, Liaoning Province, People’s Republic of China; 2Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, Liaoning Province, People’s Republic of China; 3General Surgery Liaoning Cancer Hospital and Institute, Shenyang, Liaoning Province, People’s Republic of China
Purpose: Zinc finger SWIM-type containing 5 (ZSWIM5) is a newly discovered protein, which contains a novel zinc-chelating domain SWIM (CxCxnCxH), and is predicted to interact with DNA or proteins. Currently, the knowledge of functions of ZSWIM5 remains limited. In this study, we aimed to elucidate the biological functions of ZSWIM5 and their mechanisms.
Patients and methods: We detected the expression of ZSWIM5 in samples from 139 cases of non-small-cell lung cancer (NSCLC) patients and six cell lines using immunohistochemistry and Western blot. Moreover, we explored the biological functions of ZSWIM5 in lung cancer cells by siRNA interference and cDNA transfection of ZSWIM5.
Results: The results showed that compared with adjacent non-tumor lung tissues, ZSWIM5 expression was significantly decreased in NSCLC tissues (P=0.0199) and that the ZSWIM5-positive rate in non-tumor tissues (76.67%) was notably higher than that in NSCLC tissues (40.29%). ZSWIM5 expression in human normal bronchial epithelial cells was also much higher than that in lung cancer lines (P<0.001). ZSWIM5-negative expression was significantly related to TNM stage (P<0.001), lymph node metastasis (P=0.002), and poor prognosis (P<0.001) of NSCLC patients. MTT and colony formation assays showed that ZSWIM5 could inhibit the proliferation and colony formation abilities of lung cancer cells. Meanwhile, the results of transwell and wound healing assays showed that ZSWIM5 could suppress the invasion and migration of lung cancer cells. Further investigation revealed that ZSWIM5 could downregulate cyclin D1, cyclin E, cyclin A2, MMP2, and MMP9 expression, which affected the proliferation, invasion, and migration abilities of lung cancer cells.
Conclusion: ZSWIM5 could inhibit the malignant progression of NSCLC by affecting the expression of cyclins and MMPs.
Keywords: NSCLC, zinc finger, proliferation, invasion, migration
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]